HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
25 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
FLNB
filamin B
Chromosome 3 Β· 3p14.3
NCBI Gene: 2317Ensembl: ENSG00000136068.17HGNC: HGNC:3755UniProt: O75369
270PubMed Papers
25Diseases
0Drugs
154Pathogenic Variants
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
focal adhesioncadherin bindingcytoplasmcytosolLarsen syndromeatelosteogenesis type Iatelosteogenesis type IIIspondylocarpotarsal synostosis syndrome
✦AI Summary

Filamin B (FLNB) is an actin-binding protein that connects cell membrane constituents to the actin cytoskeleton and anchors transmembrane proteins through interactions with actin filaments 1. FLNB functions as a critical regulator of cell migration and skeletal development. Mechanistically, FLNB regulates cellular processes through multiple pathways: it promotes actin cytoskeletal organization essential for cell morphology, it is targeted for ubiquitination and degradation by MTMR7 in spermatogonial stem cells to regulate Ξ²-catenin signaling and cell migration 2, and low FLNB levels confer an elongated shape to Th2 lymphocytes facilitating integrin-dependent migration 3. FLNB is required for palatal development during embryogenesis 1 and for maintaining skeletal joint integrity; its absence causes progressive vertebral fusions characteristic of spondylocarpotarsal synostosis syndrome 4. Beyond skeletal disorders, FLNB dysfunction impairs ciliogenesis and left-right patterning, linking it to congenital heart disease and heterotaxy syndrome 5. Clinically, FLNB loss-of-function variants cause non-syndromic orofacial clefts and multiple syndromic skeletal dysplasias 1. FLNB expression levels in monocytes correlate with osteoclast resorptive activity, suggesting potential therapeutic relevance in osteoporosis 6.

Sources cited
1
FLNB is an actin-binding protein implicated in bone formation and palatal development; loss-of-function variants cause non-syndromic orofacial clefts
PMID: 37003352
2
MTMR7 regulates FLNB through ubiquitination and degradation to control spermatogonial stem cell proliferation and migration via Ξ²-catenin signaling
PMID: 40638605
3
Low FLNB levels confer elongated shape to Th2 lymphocytes and facilitate Ξ±VΞ²3 integrin-dependent cell migration
PMID: 39639023
4
FLNB is required for maintenance of skeletal joints; its absence causes progressive vertebral fusions and spondylocarpotarsal synostosis syndrome phenotype
PMID: 17635842
5
FLNB dysfunction impairs ciliogenesis and left-right patterning, causing congenital heart disease and heterotaxy syndrome through actin cytoskeletal disruption
PMID: 41279393
6
FLNB expression in monocytes is predictive of osteoclast resorptive activity and bone resorption
PMID: 38263167
Disease Associationsβ“˜25
Larsen syndromeOpen Targets
0.83Strong
atelosteogenesis type IOpen Targets
0.78Strong
atelosteogenesis type IIIOpen Targets
0.77Strong
spondylocarpotarsal synostosis syndromeOpen Targets
0.76Strong
Boomerang dysplasiaOpen Targets
0.74Strong
Spondylocarpotarsal synostosisOpen Targets
0.68Moderate
Autosomal dominant Larsen syndromeOpen Targets
0.68Moderate
open-angle glaucomaOpen Targets
0.49Moderate
Joubert syndrome and related disordersOpen Targets
0.48Moderate
genetic disorderOpen Targets
0.42Moderate
filamin-related bone disorderOpen Targets
0.42Moderate
glaucomaOpen Targets
0.40Moderate
connective tissue diseaseOpen Targets
0.38Weak
FLNB-associated autosomal dominant filamin related bone disorderOpen Targets
0.37Weak
aortic valve diseaseOpen Targets
0.37Weak
adrenal gland hyperfunctionOpen Targets
0.33Weak
hyperaldosteronismOpen Targets
0.33Weak
placental retentionOpen Targets
0.33Weak
facial painOpen Targets
0.32Weak
aortic stenosisOpen Targets
0.32Weak
Atelosteogenesis 1UniProt
Atelosteogenesis 3UniProt
Boomerang dysplasiaUniProt
Larsen syndromeUniProt
Spondylocarpotarsal synostosis syndromeUniProt
Pathogenic Variants154
NM_001457.4(FLNB):c.679G>A (p.Glu227Lys)Pathogenic
Larsen syndrome|not provided|FLNB-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 227
NM_001457.4(FLNB):c.502G>A (p.Gly168Ser)Pathogenic
not provided|Larsen syndrome|See cases|FLNB-related disorder|Inborn genetic diseases|Atelosteogenesis type III;Atelosteogenesis type I;Boomerang dysplasia;Spondylocarpotarsal synostosis syndrome;Larsen syndrome
β˜…β˜…β˜†β˜†2026β†’ Residue 168
NM_001457.4(FLNB):c.4387C>T (p.Arg1463Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 1463
NM_001457.4(FLNB):c.4185C>A (p.Tyr1395Ter)Pathogenic
FLNB-related disorder|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1395
NM_001457.4(FLNB):c.5071G>A (p.Gly1691Ser)Pathogenic
Larsen syndrome|not provided|Atelosteogenesis type III;Larsen syndrome;Spondylocarpotarsal synostosis syndrome;Atelosteogenesis type I;Boomerang dysplasia
β˜…β˜…β˜†β˜†2025β†’ Residue 1691
NM_001457.4(FLNB):c.1945C>T (p.Arg649Ter)Pathogenic
Spondylocarpotarsal synostosis syndrome|FLNB-Related Spectrum Disorders|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 649
NM_001457.4(FLNB):c.5375_5377del (p.Glu1792del)Likely pathogenic
Patellar hypoplasia;Knee dislocation;Limited knee flexion/extension|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1792
NM_001457.4(FLNB):c.1740dup (p.Ser581fs)Pathogenic
See cases|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 581
NM_001457.4(FLNB):c.5110-1G>ALikely pathogenic
not provided
β˜…β˜…β˜†β˜†2025
NM_001457.4(FLNB):c.4112C>A (p.Ser1371Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 1371
NM_001457.4(FLNB):c.482T>G (p.Phe161Cys)Likely pathogenic
Larsen syndrome|Connective tissue disorder|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 161
NM_001457.4(FLNB):c.500A>G (p.Asp167Gly)Likely pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 167
NM_001457.4(FLNB):c.5072G>A (p.Gly1691Asp)Pathogenic
Larsen syndrome|Abnormality of the skeletal system|not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 1691
NM_001457.4(FLNB):c.1592dup (p.His532fs)Pathogenic
Spondylocarpotarsal synostosis syndrome
β˜…β˜…β˜†β˜†2023β†’ Residue 532
NM_001457.4(FLNB):c.6616G>T (p.Gly2206Ter)Pathogenic
not provided
β˜…β˜…β˜†β˜†2022β†’ Residue 2206
NM_001457.4(FLNB):c.5842C>T (p.Arg1948Ter)Pathogenic
not provided|Spondylocarpotarsal synostosis syndrome
β˜…β˜…β˜†β˜†2022β†’ Residue 1948
NM_001457.4(FLNB):c.1082G>A (p.Gly361Asp)Pathogenic
not provided|Larsen syndrome
β˜…β˜…β˜†β˜†2020β†’ Residue 361
NM_001457.4(FLNB):c.4713_4715del (p.Asn1571del)Likely pathogenic
Larsen syndrome
β˜…β˜†β˜†β˜†2026β†’ Residue 1571
NM_001457.4(FLNB):c.950_951del (p.Val317fs)Likely pathogenic
Spondylocarpotarsal synostosis syndrome
β˜…β˜†β˜†β˜†2026β†’ Residue 317
NM_001457.4(FLNB):c.2998del (p.Glu1000fs)Likely pathogenic
Short stature
β˜…β˜†β˜†β˜†2026β†’ Residue 1000
View on ClinVar β†—
Related Genes
SMTNL2Shared pathway100%THSD7AShared pathway100%PHACTR3Shared pathway100%SPECC1Shared pathway100%THSD7BShared pathway100%PHACTR2Shared pathway100%
Tissue Expression6 tissues
Liver
100%
Ovary
100%
Lung
58%
Heart
50%
Bone Marrow
41%
Brain
28%
Gene Interaction Network
Click a node to explore
FLNBSMTNL2THSD7APHACTR3SPECC1THSD7BPHACTR2
PROTEIN STRUCTURE
Preparing viewer…
PDB2WA7 Β· 1.85 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.50Moderately Constrained
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.43 [0.37–0.50]
RankingsWhere FLNB stands among ~20K protein-coding genes
  • #1,363of 20,598
    Most Researched270 Β· top 10%
  • #494of 5,498
    Most Pathogenic Variants154 Β· top 10%
  • #3,046of 17,882
    Most Constrained (LOEUF)0.50 Β· top quartile
Genes detectedFLNB
Sources retrieved25 papers
Response timeβ€”
πŸ“„ Sources
25β–Ό
1
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
1.00
2
MTMR7 regulates human spermatogonial stem cells proliferation and migration via targeting FLNB.
PMID: 40638605
PLoS One Β· 2025
0.90
3
Proteomic and secretomic comparison of young and aged dermal fibroblasts highlights cytoskeleton as a key component during aging.
PMID: 39197170
Aging (Albany NY) Β· 2024
0.80
4
Rare loss-of-function variants in FLNB cause non-syndromic orofacial clefts.
PMID: 37003352
J Genet Genomics Β· 2024
0.80
5
Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity.
PMID: 38263167
Bone Res Β· 2024
0.70